'Metastatic renal cell carcinoma' presentation slideshows

Eyas M. Hattab , M.D. Department of Pathology and Laboratory Medicine

1.01k views • 101 slides

Optimizing Dose Intensity of Treatment for Patients With Metastatic Renal Cell Carcinoma

Optimizing Dose Intensity of Treatment for Patients With Metastatic Renal Cell Carcinoma. Activity Goals. Outline. VEGF TKIs for mRCC. Case 1. Case 1: Treatment Options. Case 1: Enrolled in a Clinical Trial. Case 1 (cont) . Case 2 . Case 2 (cont). Early Adverse Effects of TKIs.

756 views • 57 slides

Phase III Trial of Pazopanib in Locally Advanced and/or Metastatic Renal Cell Carcinoma

Phase III Trial of Pazopanib in Locally Advanced and/or Metastatic Renal Cell Carcinoma . Sternberg CN et al. ASCO 2009; Abstract 5021. (Oral Presentation). Introduction. Pazopanib, an oral angiogenesis inhibitor, has high affinity for PDGFR and VEGFR 1, 2 and 3 and also targets C-kit

550 views • 16 slides

Amoebic Dysentery

Bobby Shore and Brooke Whipkey. Amoebic Dysentery. What is Amoebic Dysentery. Amoebic Dysentery is an intestinal illness witch causes the lining of the large intestines to become inflamed . The illness is caused by a protozoan called Entamoeba Histolytica.

471 views • 13 slides

458 views • 11 slides

Kaplein-Meier estimates of OS for patients who did not receive any post-study treatment

Kaplein-Meier estimates of OS for patients who did not receive any post-study treatment. Treatment algorithm for metastatic renal cell carcinoma.

101 views • 2 slides